GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gennbio Inc (XKRX:072520) » Definitions » FCF Margin %

Gennbio (XKRX:072520) FCF Margin % : -11,812.23% (As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Gennbio FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Gennbio's Free Cash Flow for the three months ended in Mar. 2024 was ₩-2,522 Mil. Gennbio's Revenue for the three months ended in Mar. 2024 was ₩21 Mil. Therefore, Gennbio's FCF Margin % for the quarter that ended in Mar. 2024 was -11,812.23%.

As of today, Gennbio's current FCF Yield % is -17.62%.

The historical rank and industry rank for Gennbio's FCF Margin % or its related term are showing as below:

XKRX:072520' s FCF Margin % Range Over the Past 10 Years
Min: -760.83   Med: -162.71   Max: 12.26
Current: -188.74


During the past 13 years, the highest FCF Margin % of Gennbio was 12.26%. The lowest was -760.83%. And the median was -162.71%.

XKRX:072520's FCF Margin % is not ranked
in the Biotechnology industry.
Industry Median: -143.325 vs XKRX:072520: -188.74


Gennbio FCF Margin % Historical Data

The historical data trend for Gennbio's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gennbio FCF Margin % Chart

Gennbio Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -306.15 -169.55 -760.83 -430.00 -155.86

Gennbio Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -217.11 -38.57 -238.37 -163.43 -11,812.23

Competitive Comparison of Gennbio's FCF Margin %

For the Biotechnology subindustry, Gennbio's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gennbio's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gennbio's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Gennbio's FCF Margin % falls into.



Gennbio FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Gennbio's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-8242.95/5288.698
=-155.86 %

Gennbio's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-2521.911/21.35
=-11,812.23 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gennbio FCF Margin % Related Terms

Thank you for viewing the detailed overview of Gennbio's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Gennbio Business Description

Traded in Other Exchanges
N/A
Address
5th Floor, Teheran Road, Gangnam-gu, 422 KT Seolleung Tower, Seoul, KOR
Gennbio Inc builds drug and bio long-term development platform. The company produces models of primate diseases such as organ transplants and immune or diabetic models.

Gennbio Headlines

No Headlines